Chemogenetic activation of locus coeruleus neurons ameliorates the severity of multiple sclerosis

Abstract Background Most current disease-modifying therapies approved for multiple sclerosis (MS) are immunomodulatory drugs that counteract the aberrant activity of the immune system. Hence, new pharmacological interventions that drive anti-inflammatory activity and neuroprotection would represent...

Full description

Bibliographic Details

Published in:	Journal of Neuroinflammation
Main Authors:	Alejandro Torrillas-de la Cal, Sonia Torres-Sanchez, Lidia Bravo, Meritxell Llorca-Torralba, Jose Antonio Garcia-Partida, Ana I. Arroba, Esther Berrocoso
Format:	Article
Language:	English
Published:	BMC 2023-09-01
Subjects:	Multiple sclerosis Experimental autoimmune encephalomyelitis Locus coeruleus Noradrenaline Spinal cord
Online Access:	https://doi.org/10.1186/s12974-023-02865-z